Fed. Circ. Backs Nix Of GSK Flu Inhaler Patent Application
A divided Federal Circuit panel affirmed the Patent Trial and Appeal Board's rejection of a GlaxoSmithKline PLC application for a patent on a drug inhaler to treat influenza, ruling Tuesday that...To view the full article, register now.
Already a subscriber? Click here to view full article